A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
News|Slideshows|October 12, 2016
Politics Govern Treatment and More Medical News
Author(s)Leo Robert
Do doctors’ politics affect treatment decisions on, for example, drug use, firearms, and sexual behavior? Do yours?
Advertisement
Politics driving treatment decisions, a depression epidemic, cardiovascular risk with statins vs nonstatins-we offer these and other highlights of recent clinical studies of interest to primary care physicians.Scroll through the slides above for key findings. Original sources are below.
References:
Advertisement
Related to this article
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5